$0.32
8.77% today
Nasdaq, Aug 18, 10:16 pm CET
ISIN
US1897631057
Symbol
CODX

Co-Diagnostics, Inc. Stock price

$0.29
+0.03 10.15% 1M
-0.40 57.34% 6M
-0.46 60.77% YTD
-0.95 76.27% 1Y
-4.02 93.17% 3Y
-15.43 98.13% 5Y
-5.52 94.94% 10Y
-5.52 94.94% 20Y
Nasdaq, Closing price Fri, Aug 15 2025
+0.03 10.85%

Key metrics

Basic
Market capitalization
$9.7m
Enterprise Value
$-11.8m
Net debt
positive
Cash
$21.5m
Shares outstanding
33.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.8 | 20.0
EV/Sales
negative | negative
EV/FCF
0.4
P/B
0.2
Financial Health
Equity Ratio
84.9%
Return on Equity
-69.3%
ROCE
-77.1%
ROIC
-124.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$3.5m | $484.5k
EBITDA
$-37.1m | -
EBIT
$-38.4m | $-31.7m
Net Income
$-35.9m | $-36.6m
Free Cash Flow
$-29.9m
Growth (TTM | estimate)
Revenue
-47.6% | -87.6%
EBITDA
11.3% | -
EBIT
10.8% | 20.8%
Net Income
7.8% | 2.7%
Free Cash Flow
-12.0%
Margin (TTM | estimate)
Gross
77.5%
EBITDA
-1,059.2% | -
EBIT
-1,097.2%
Net
-1,025.3% | -7,562.1%
Free Cash Flow
-853.4%
More
EPS
$-1.1
FCF per Share
$-0.9
Short interest
1.9%
Employees
132
Rev per Employee
$30.0k
Show more

Is Co-Diagnostics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Co-Diagnostics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Co-Diagnostics, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Co-Diagnostics, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Co-Diagnostics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
3.50 3.50
48% 48%
100%
- Direct Costs 0.79 0.79
80% 80%
23%
2.71 2.71
2% 2%
77%
- Selling and Administrative Expenses 20 20
6% 6%
560%
- Research and Development Expense 20 20
15% 15%
576%
-37 -37
11% 11%
-1,059%
- Depreciation and Amortization 1.33 1.33
6% 6%
38%
EBIT (Operating Income) EBIT -38 -38
11% 11%
-1,096%
Net Profit -36 -36
8% 8%
-1,025%

In millions USD.

Don't miss a Thing! We will send you all news about Co-Diagnostics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Co-Diagnostics, Inc. Stock News

Neutral
PRNewsWire
about 8 hours ago
SALT LAKE CITY , Aug. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it will be hosting a booth at the 17th Annual Next Generation Dx Summit, held virtually and in-person at the Capital Hilton in Washington, D.C. on Au...
Neutral
Seeking Alpha
4 days ago
Co-Diagnostics, Inc. (NASDAQ:CODX ) Q2 2025 Earnings Conference August 14, 2025 4:30 PM ET Company Participants Andrew Benson - Head of Investor Relations Brian L. Brown - CFO & Company Secretary Dwight H.
Neutral
PRNewsWire
4 days ago
SALT LAKE CITY , Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended June 30, 2025. Second Quarter 2025 Financial Results: Revenue of $0.2 million, which declined from $2.7 million during Q2 2024 primarily due ...
More Co-Diagnostics, Inc. News

Company Profile

Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Head office United States
CEO Dwight Egan
Employees 132
Founded 2013
Website codiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today